"Saint Joseph Mercy Health System (SJMHS) is a health care organization serving seven counties in southeast Michigan including Livingston, Washtenaw, Wayne, Oakland, Macomb, Jackson, and Lenawee. It includes 548-bed St. Joseph Mercy Ann Arbor, 497-bed St. Joseph Mercy Oakland in Pontiac, 304-bed St. Mary Mercy Livonia, 66-bed St. Joseph Mercy Livingston in Howell, and 133-bed St. Joseph Mercy Chelsea."

During the past decade, Saint Mary Mercy Hospital conducted 83 clinical trials. In the 10-year time frame, 83 clinical trials started and 208 clinical trials were completed, i.e. on average, 250.6% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 74 clinical trials were completed. i.e. 308.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Mary Mercy Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 89 trials, followed by "SWOG Cancer Research Network" with 72 trials sponsored, "National Cancer Institute (NCI)" with 60 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 17 trials sponsored and "Gynecologic Oncology Group" with 17 trials sponsored. Other sponsors include 46 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Mary Mercy Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 238 trials as a collaborator, "NRG Oncology" with 28 trials as a collaborator, "Cancer and Leukemia Group B" with 8 trials as a collaborator, "NCIC Clinical Trials Group" with 7 trials as a collaborator and "SWOG Cancer Research Network" with 7 trials as a collaborator. Other collaborators include 65 different institutions and companies that were collaborators in the rest 46 trials.

According to Clinical.Site data, the most researched conditions in "Saint Mary Mercy Hospital" are "Breast Cancer" (34 trials), "Lung Cancer" (24 trials), "Lymphoma" (11 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (11 trials) and "Colorectal Cancer" (10 trials). Many other conditions were trialed in "Saint Mary Mercy Hospital" in a lesser frequency.

Most popular intervention types in "Saint Mary Mercy Hospital" are "Drug" (242 trials), "Other" (154 trials), "Biological" (78 trials), "Radiation" (44 trials) and "Procedure" (28 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (59 trials), "Quality-of-Life Assessment" (43 trials), "placebo" (29 trials), "Questionnaire Administration" (26 trials) and "Paclitaxel" (25 trials). Other intervention names were less common.

The vast majority of trials in "Saint Mary Mercy Hospital" are 222 trials for "All" genders, 68 trials for "Female" genders and 14 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Mary Mercy Hospital". undefined are not yet recruiting, 19 are recruiting, 70 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 177 completed trials in Saint Mary Mercy Hospital, 3 suspended trials, and 29 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Mary Mercy Hospital, 13 "Phase 1" clinical trials were conducted, 163 "Phase 2" clinical trials and 119 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".